-
Product Insights
Frozen Shoulder Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Frozen Shoulder Syndrome Clinical Trials Market Report Overview The Frozen Shoulder Syndrome clinical trial market research report provides an overview of the Frozen Shoulder Syndrome Clinical trials scenario. This report provides top-line data relating to the clinical trials on Frozen Shoulder Syndrome. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Sector Analysis
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Report Overview PsA is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and the sacroiliac joints of the pelvis. Clinical diagnosis and assessment of PsA involve a combination of patient history, physical examination, laboratory tests, and imaging studies. The goal of diagnosis and assessment is to identify the presence and extent of joint involvement, assess...
-
Product Insights
Spondyloarthritis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Canada ERCP and PTC Procedures Market Report Overview The total number of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Procedures performed in Canada was 104,215 in 2022. ERCP is a combined endoscopic and radiologic procedure for the ducts draining the liver and pancreas which includes bile ducts, gallbladder and pancreatic ducts. ERCP endoscopes are also used for the removal of gallstones from the bile ducts, dilating structures, or placing stents in blocked ducts to hold them open, all...
-
Product Insights
Ankylosing Spondylitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Ankylosing Spondylitis Clinical Trials Market Report Overview The Ankylosing Spondylitis clinical trial market research report provides an overview of Ankylosing Spondylitis clinical trials scenario. The report provides top-line data relating to the clinical trials on Ankylosing Spondylitis. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. Key...
-
Product Insights
Prosthetic Joint Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
PJI Pipeline Products Market Report Overview Prosthetic joint infection (PJI) is one of the most serious complications of prosthetic joint implantation. Symptoms include pain or stiffness in joints, swelling, redness around the wound, fatigue, and fever. Risk factors include age, prior arthroplasty, poor nutritional status, obesity, diabetes mellitus, and advanced HIV disease. Treatment includes antimicrobial therapy. The PJI pipeline market research report provides comprehensive information on the therapeutics under development for PJI, complete with analysis by stage of development, drug...
-
Product Insights
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Fibrodysplasia ossificans progressiva (FOP) is a disorder in which muscle tissue and connective tissue such as tendons and ligaments are gradually replaced by bone (ossified), forming bone outside that constrains movement. Symptoms swellings in fibrous tissue, pain, fever, muscle ossification, and restricted movement of joints. Treatment includes surgery and medications to help relieve symptoms of FOP, such as pain and inflammation. The FOP pipeline products market research report provides comprehensive information on the therapeutics under development for FOP, complete with...
-
Product Insights
Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big toe. Gout occurs when uric acid builds up in the blood and causes inflammation in the joints. Symptoms include sudden onset of joint pain, joint swelling, heat in the affected area, and joint redness. Risk factors include obesity, high alcohol intake, injury to joints, long-standing kidney disease, and high intake of foods rich in purines. The Gouty Arthritis (Gout)...
-
Product Insights
Muscular Dystrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Muscular Dystrophy Pipeline Drugs Market Report Overview Muscular dystrophy is a group of diseases in which muscle fibers are unusually susceptible to damage. These damaged muscles become progressively weaker. Symptoms usually appear before age 6 and may appear as early as infancy. They may include fatigue, learning difficulties, intellectual disability, muscle weakness, and progressive difficulty walking. The report titled ‘Muscular Dystrophy –Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update’, provides an overview of...
-
Product Insights
Pigmented Villonodular Synovitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pigmented Villonodular Synovitis (PVNS) is a condition that causes synovium. PVNS is characterized by inflammation and overgrowth of the joint lining. This affects the hip or knee. Symptoms include pain, swelling in the affected joint, locking, catching, and instability in the joint. Treatment includes surgery and radiation therapy. The PVNS pipeline drugs market research report provides comprehensive information on the therapeutics under development for Pigmented Villonodular Synovitis, complete with analysis by stage of development, drug target, mechanism of action (MoA),...
-
Product Insights
Dermatomyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Dermatomyositis is a rare inflammatory disease that is characterized by chronic muscle inflammation accompanied by muscle weakness. Symptoms of dermatomyositis include a distinctive skin rash, muscle weakness, and inflammatory myopathy or inflamed muscles. Risk factors include age and gender. Treatment includes corticosteroids. The Dermatomyositis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Dermatomyositis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The...
-
Product Insights
Ankylosing Spondylitis (Bekhterev’s Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. The Ankylosing Spondylitis pipeline drugs market research report provides comprehensive information on the therapeutics under development for ankylosing spondylitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The...
-
Product Insights
Axial Spondyloarthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Axial spondylitis is a type of inflammatory arthritis involving the spine and/or sacroiliac joints. Axial spondylitis is strongly related to the presence of the HLA-B27 gene. A genetic test for HLA-B27 is available. The Axial Spondyloarthritis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Axial Spondyloarthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action...
-
Product Insights
Psoriatic Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis. Symptoms include swollen fingers and toes, foot pain, and lower back pain. Risk factors include age, family history, and psoriasis. Treatment includes NSAIDs, immunosuppressants, and surgery. The Psoriatic Arthritis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Psoriatic Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The...
-
Product Insights
Osteonecrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Osteonecrosis is bone death caused by the poor blood supply to the area. It is most common in the hip and shoulder but can affect other large joints such as the knee, elbow, wrist, and ankle. Osteonecrosis can be caused by disease, or severe trauma, such as a break or dislocation, that affects the blood supply to the bone. There are no symptoms in the early stages. The Osteonecrosis pipeline drugs market report provides comprehensive information on the therapeutics under...
-
Sector Analysis
Axial Spondyloarthritis (axSpA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Axial Spondyloarthritis, a chronic autoinflammatory disorder of the sacroiliac joints and spine, causes can occur with symptoms like fatigue, spinal pain, arthralgia (joint pain) or swelling, enthesitis (inflammation of the entheses), and morning stiffness. There are millions of diagnosed prevalent cases of axial Spondyloarthritis worldwide. The Axial Spondyloarthritis marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, late-stage pipeline products with phase transition success rate (PTSR), and likelihood of approval (LoA) for axSpA....
-
Sector Analysis
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2031
Osteoarthritis Market Overview The osteoarthritis market size was valued at $2.5 billion in 2021 and is expected to achieve a CAGR of more than 4% during 2021-2031. OA is a slowly progressive joint disease characterized by degradation of the articular (hyaline) cartilage that coats the bone proximities of synovial joints. Contrary to the previous notion that OA is exclusively a disorder of articular cartilage, studies have demonstrated it is a disease of the whole joint, adversely affecting the subchondral bone,...
-
Product Insights
Psoriatic Arthritis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
The Psoriatic Arthritis clinical trial market research report provides an overview and top-line data relating to the clinical trials on Psoriatic Arthritis. The report includes an overview of trials count and their average enrollment in top countries conducted globally. It also includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status, and sponsor type. The report also provides prominent drug names and trial counts for in-progress trials (based on the number of...
-
Product Insights
Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Inclusion Body Myositis (IBM) is one of the inflammatory myopathies that involve inflammation of the muscles or associated tissues, such as the blood vessels that supply the muscles. IBM symptoms include progressive weakness of the muscles of the wrists and fingers, the muscles of the front of the thigh, and the muscles that lift the front of the foot. The IBM pipeline drugs market research report outlays comprehensive information on the IBM targeted therapeutics, complete with analysis by indications, stage...
-
Sector Analysis
Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Polymyositis and Dermatomyositis pipeline market research report includes an assessment of the disease epidemiology, leading marketed products, late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR), and Likelihood of Approval (LoA) for polymyositis and dermatomyositis (PM and DM). The report also analyzes the clinical and commercial landscapes of PM and DM, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment. Patients with PM and DM usually present with sub-acute or chronic...
-
Sector Analysis
Osteoarthritis Epidemiology Analysis and Forecast, 2021-2031
Osteoarthritis (OA) market size was 18,820,737 cases in 2021 cases across 7MM. The market is expected to grow at an AGR of more than 1% during the forecast period. The osteoarthritis epidemiology market research report provides an overview of the risk factors, comorbidities, and global and historical trends for hand OA, knee OA, and hip OA in the seven major markets or 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.